[HTML][HTML] A critical review of the evidence that metformin is a putative anti-aging drug that enhances healthspan and extends lifespan

I Mohammed, MD Hollenberg, H Ding… - Frontiers in …, 2021 - frontiersin.org
The numerous beneficial health outcomes associated with the use of metformin to treat
patients with type 2 diabetes (T2DM), together with data from pre-clinical studies in animals …

[HTML][HTML] Growth/differentiation factor-15 (GDF-15): from biomarker to novel targetable immune checkpoint

J Wischhusen, I Melero, WH Fridman - Frontiers in Immunology, 2020 - frontiersin.org
Growth/differentiation factor-15 (GDF-15), also named macrophage inhibitory cytokine-1, is a
divergent member of the transforming growth factor β superfamily. While physiological …

[HTML][HTML] The roles of PD-1/PD-L1 in the prognosis and immunotherapy of prostate cancer

Y Xu, G Song, S Xie, W Jiang, X Chen, M Chu, X Hu… - Molecular Therapy, 2021 - cell.com
Multiple studies have confirmed that programmed cell death 1/programmed cell death ligand-
1 (PD-1/PD-L1) and immune checkpoint inhibitors (ICIs) targeting PD-1/PD-L1 play pivotal …

[HTML][HTML] GDF15/GFRAL pathway as a metabolic signature for cachexia in patients with cancer

DS Ahmed, S Isnard, J Lin, B Routy, JP Routy - Journal of Cancer, 2021 - ncbi.nlm.nih.gov
Cachexia is a metabolic mutiny that directly reduces life expectancy in chronic conditions
such as cancer. The underlying mechanisms associated with cachexia involve inflammation …

[HTML][HTML] The roles of FGF21 and GDF15 in mediating the mitochondrial integrated stress response

J Jena, LM García-Peña, RO Pereira - Frontiers in Endocrinology, 2023 - frontiersin.org
Various models of mitochondrial stress result in induction of the stress-responsive cytokines
fibroblast growth factor 21 (FGF21) and growth differentiation factor 15 (GDF15). This is an …

FOXM1 mediates GDF-15 dependent stemness and intrinsic drug resistance in breast cancer

A Modi, P Purohit, D Roy, JR Vishnoi, P Pareek… - Molecular Biology …, 2022 - Springer
Background Stemness, a key component of breast cancer (BC) heterogeneity, is responsible
for chemoresistance. Growth differentiation factor-15 (GDF-15) induces drug resistance and …

[HTML][HTML] Short-term ex vivo culture of CTCs from advance breast cancer patients: clinical implications

N Carmona-Ule, M González-Conde, C Abuín… - Cancers, 2021 - mdpi.com
Simple Summary Circulating tumor cells (CTCs) are responsible for metastasis, they
represent tumor biology and have also predictive value for therapy monitoring and …

[HTML][HTML] Targeting stress erythropoiesis pathways in cancer

S Vignjević Petrinović, A Jauković, M Milošević… - Frontiers in …, 2022 - frontiersin.org
Cancer-related anemia (CRA) is a common multifactorial disorder that adversely affects the
quality of life and overall prognosis in patients with cancer. Safety concerns associated with …

[HTML][HTML] The role of growth differentiation factor 15 in energy metabolism

JY Chang, HJ Hong, SG Kang, JT Kim… - Diabetes & …, 2020 - synapse.koreamed.org
Abstract Growth differentiation factor 15 (GDF15) is receiving great interest beyond its role
as an aging and disease-related biomarker. Recent discovery of its receptor, glial cell line …

[HTML][HTML] A combined analysis of serum growth differentiation factor-15 and cancer antigen 15-3 enhances the diagnostic efficiency in breast cancer

A Modi, P Purohit, A Gadwal, D Roy, S Fernandes… - Ejifcc, 2021 - ncbi.nlm.nih.gov
Results The serum GDF-15 levels were significantly (p< 0.001) elevated in BC patients
compared to healthy controls and in patients with larger tumor size, advanced disease …